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Zika virus is named for the Zika Forest in Uganda and was 
first discovered in 1947 in primates. The first human cases of 
Zika virus infection were detected in 1952. From about 1960–
1980, human infections occurred across Asia and Africa, 
although infections were typically mild with limited symp-
toms. The first major human outbreak occurred in Micronesia 
in 2007. Zika was linked to a neurological disorder (Guillain-
Barré syndrome, or GBS) during a 2013–2014 outbreak in 
French Polynesia. In May 2015, the first human cases were 
reported in Brazil and a link to GBS was also reported. Other 
symptoms of Zika infection include rash, fever, conjunctivitis 
and joint pain. Only approximately 20% of infected individu-
als experience clinical symptoms (http://www.cdc.gov/zika/
symptoms/symptoms.html). Brazil reported an association 
between Zika viral infections and microcephaly in October 
2015. Microcephaly is a disorder in which the head of a new-
born child is disproportionally small relative to the body. It 
may result from a variety of chromosomal and environmen-
tal causes, including drug, alcohol, or radiation exposure and 
prenatal infections (rubella, herpes simplex, and likely Zika 
virus) (Merck Manual, 2016). As of August 3, 2016, evidence 
of mosquito-borne Zika virus transmission has been reported 
in 68 countries and territories and 14 countries or territories 
have reported microcephaly and other central nervous system 
(CNS) malformations associated with Zika virus.
As of August 3, 2016, evidence of mosquito-borne Zika 
virus transmission has been reported in 68 countries and terri-
tories and 14 countries or territories have reported microcephaly 
and other central nervous system (CNS) malformations associ-
ated with Zika virus. From January 1, 2015 through September 
7, 2016, there have been 2,920 U.S. travel-associated cases 
reported, 43 locally-acquired mosquito-borne cases reported 
and one laboratory acquired case reported for a total of 2,964 
cases (24 sexually transmitted and seven with GBS association) 
(http://www.cdc.gov/zika/about/overview.html and http://
www.who.int/emergencies/zika-virus/timeline/en/). At 
the time of this report, all U.S. states except for Wyoming had 
confirmed traveler-related Zika virus cases.
The first U.S. case of locally-transmitted (victim did not 
travel) mosquito-borne Zika virus was reported in Miami, 
Florida on July 29, 2016 and all local U.S. cases (as of September 
7, 2016) have been restricted to the state of Florida. The U.S 
Territories of Puerto Rico, American Samoa and the U.S. 
Virgin Islands have reported (as of September 7, 2016) 15,809 
local and 60 travel-associated cases of Zika virus infection.
Zika virus is primarily spread through the bite of an 
infected mosquito of the species Aedes aegypti (the yellow 
fever mosquito) or Ae. albopictus (the Asian tiger mosquito). 
Maps showing the approximate distribution of these species 
in the U.S. show that Ae. albopictus is more widespread than 
Ae. aegypti, although caution is advised in interpretation, since 
mosquito surveillance may be inadequate in some areas (Hahn, 
et al. 2016). These species of mosquitoes lay eggs primarily 
in artificial containers holding standing water. Aedes aegypti 
females prefer to blood feed on humans, while Ae. albopictus 
females are opportunistic feeders, blood feeding on a variety 
of hosts, including humans. Both Ae. aegypti and Ae. albopictus 
are primarily active and blood feed in the daytime. When mos-
quitoes bite a person infected with the virus, they may become 
infected; however, not all mosquitoes can become infected 
with and transmit viruses. Mosquitoes that are competent 
vectors (ie, able to transmit Zika virus) can pass the virus to 
humans through their subsequent blood meals. A pregnant 
woman who is bitten by a Zika virus-infected mosquito may 
pass the virus to her fetus, which may result in microcephaly 
and/or other complications in the developing fetus and new-
born child. Zika virus may also be passed through sexual 
contact, even if the infected person shows no symptoms. Zika 
virus may also be transmitted through transfusion of infected 
blood and laboratory exposure, although the exact mechanism 
of the laboratory transmission is unclear (http://www.who.int/
topics/zika/en/, http://www.cdc.gov/zika/transmission/index.
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html). There is some evidence (in mice) that Zika virus impacts 
adult brain cells and these effects may be present in immu-
nocompromised or healthy individuals (Li et al. 2016). More 
research is needed to further investigate these effects on the 
human brain.
There is currently no vaccine for Zika virus, although 
work is currently underway to develop an emergency vac-
cine target product profile for dengue, chikungunya and Zika 
viruses. Dengue and chikungunya viruses are also mosquito 
borne pathogens of public health concern that use the same 
species of mosquito vectors as Zika virus. The current primary 
means of preventing Zika virus infections is protection against 
mosquito bites using insect repellants (DEET, Picaridin 
[LBR 3023], Bayrepel, Incaridin, oil of lemon eucalyptus 
[OLE], para-menthane-diol [PMD] or IR3535), wearing of 
long-sleeved shirts and long pants (which may be profession-
ally treated with permethrin to increase protection), and use 
of effective screens on windows and doors, air conditioning 
when available, and control of oviposition (egg-laying) areas 
(emptying and scrubbing of any outdoor items that may hold 
water such as tires, buckets, toys, pools, birdbaths, flowerpot 
water receptacles, trash containers, etc.). Sexual transmission 
of Zika virus can be limited by using safe sexual practices 
(eg, condoms or other barrier protection). Individuals plan-
ning to travel should pay attention to travel advisories pro-
vided by the U.S. Centers for Disease Control and Prevention 
(http://wwwnc.cdc.gov/travel/page/zika-travel-information) 
and the World Health Organization (http://www.who.int/csr/
disease/zika/information-for-travelers/en/). Mosquito control 
and protection from mosquito bites may have the added bene-
fit of protecting against other mosquito-borne viruses such as 
dengue and chikungunya.
As reported in a previous Environmental Health Insights 
editorial entitled “Insights into Ebola and Other Emerging 
and Re-emerging Infectious Disease Risks” (Kelley, 2014), 
it is important to recognize that the risks associated with 
emerging infectious diseases such as Zika may be covered 
more frequently by global media; however, widespread global 
issues with other mosquito-borne pathogens such as dengue 
and chikungunya viruses are also of continued concern, espe-
cially as global travel continues to increase the incidence of 
imported cases. Of course, the effects of Zika virus on preg-
nant women and their children is a serious concern with long-
lasting implications. It is important that a vaccine is developed 
as quickly as possible to limit further congenital abnormalities 
and mosquito surveillance and control is brought to the fore-
front of priorities for public health protection.
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